Navigation Links
New therapy found for rare lung disorder
Date:3/16/2011

ing lung function in women with LAM."

McCormack says LAM cells isolated from lung lesions have TSC mutations and exhibit activation of a key sirolimus-sensitive growth pathway. When exposed to the drug in culture, the growth of LAM cells is stopped.

Experiments in TSC animal models have also demonstrated that sirolimus shrinks tumors in the liver and kidneys.

The MILES study was conducted within the National Institutes of Health (NIH)-supported Rare Lung Diseases Consortium, led by UC and Cincinnati Children's physician and pulmonary biologist Bruce Trapnell, MD, and co-directed by McCormack, and involved 13 institutions from around the world. Data was reported using Internet-based systems connected to a centralized, Internet-based data coordinating center headed by Jeffrey Krischer, MD, at the University of South Florida, Tampa.

"The trial included a screening visit and a year-long double blind, placebo-controlled treatment period, followed by a year of observation," says McCormack.

All eligible participants were female, aged 18 years or older and had a confirmed diagnosis of LAM with abnormal lung function.

Patients meeting the criteria were randomly assigned to either receive an initial dose of oral sirolimus at 2 milligrams per day or a matched placebo, and sirolimus levels were measured at each follow-up visit. Results were revealed only to an independent medical monitor who made dosing recommendations to maintain serum levels within a pre-specified target range.

A total of 89 patients with LAM were enrolled in the United States, Canada and Japan. Patients underwent baseline lung function testing, and lung function and exercise outcomes were measured over the course of six visits in the first year. Participants were also given questionnaires to determine how their symptoms changed throughout the course of the study.

Researchers found that sirolimus stabilized lung function and was associ
'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Sirolimus therapy alleviates symptoms of lung disease LAM
2. Research study explores gene therapy treatment to reduce symptoms of Parkinsons disease
3. University Hospitals Case Medical Center testing innovative heat therapy for premature ejaculation
4. Ohio State study: Targeted ovarian cancer therapy not cost-effective
5. Stroke patients benefit from family involvement in exercise therapy
6. Extra Tests Not a Deterrent to Experimental Cancer Therapy
7. Gene Therapy Against HIV Not a Proven Cure, Experts Say
8. WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves
9. BUSM study shows chemoradiotherapy prior to surgery improves survival
10. Fish oil fights weight loss due to chemotherapy
11. Lack of health insurance limits hepatitis C patients access to latest antiviral therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted to have ... diabetes after many years of suffering and using medications with strong side effects. This ... ask for extra time off or wait longer hours in the waiting rooms. Instead, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle Specialists of the Mid-Atlantic ... the largest medical practice in the Mid-Atlantic region – and the second largest in ... with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. She grew up ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... International Code Council (ICC) announce an agreement to collaborate across a ... energy conservation to increasing building code knowledge among architects. , “Our combined membership, ...
(Date:8/3/2015)... ... ... Recent reports by the American Medical Association show that over 80% of ... time, low back and sciatic pain can happen as a result of vertebral disc ... pain medication or spinal surgery. Dynamic Health Care in Louisville, KY , has ...
(Date:8/2/2015)... ... ... A new Phase I research study is looking at a vaccine that ... Kenneth G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and stem ... Children’s Hospital and in the UofL Department of Pediatrics . Patients are ...
Breaking Medicine News(10 mins):Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2
... Gordon HealthDay Reporter , MONDAY, July 19 (HealthDay News) ... many people have turned to homeopathic remedies, including products containing zinc. ... and nasal swabs with zinc have most likely caused a loss ... seeing people using the zinc nasal gel. They squirted it in, ...
... Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible ... more likely today, Lady Gaga -- only hint at ... Now a data-driven review by Northwestern University researchers ... Reviews Neuroscience pulls together converging research from the ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... increase a soldier,s risk of epilepsy even years later, a ... a penetrating traumatic brain injury have high rates of epilepsy, ... lesion," said lead researcher Jordan Grafman, a senior investigator at ...
... at the International AIDS Conference in Vienna are charging ... bounce to the millions of people in need of ... numbers reported by WHO, the International Treatment Preparedness Coalition,s ... warnings of the global pullback on AIDS commitment and ...
... HealthDay Reporter , MONDAY, July 19 (HealthDay News) -- A ... risk of HIV infection by more than half, according to ... Vienna. The gel contains tenofovir (Viread), an antiretroviral drug ... women in the general population used it in the same ...
... NY JULY 20, 2010 TCT 2010 (Transcatheter ... technologies and practices in interventional cardiology that will directly ... (September 21-25 in Washington, DC), late breaking data from ... cardiology techniques, and the interactions and effectiveness of new ...
Cached Medicine News:Health News:Homeopathic Nasal Zinc Linked to Loss of Smell 2Health News:Homeopathic Nasal Zinc Linked to Loss of Smell 3Health News:Taking music seriously 2Health News:Taking music seriously 3Health News: Brain Injury May Raise Soldier's Epilepsy Risk 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 3Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 4Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 5Health News:Vaginal Gel Cuts Risk of HIV Infection, Study Shows 2Health News:Vaginal Gel Cuts Risk of HIV Infection, Study Shows 3Health News:TCT 2010 to have significant impact on interventional cardiology practices and patient care 2
(Date:7/30/2015)... Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... prior year. Reported sales decreased 4% as currency reduced ... Net earnings per diluted share as reported (EPS) were ... EPS was $2.80 , an increase of 9% ...
(Date:7/30/2015)... 30, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... Development Agreements with Dexcom, Inc. to allow the ... the Dexcom G5 and G6 continuous glucose monitoring ... pump platform with Dexcom,s future CGM systems is ...
(Date:7/30/2015)... and VANCOUVER , July 30, ... announced today that it will report its second quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... FSH EIA Test is based ... solid phase enzyme-linked immunosorbent assay. ... monoclonal anti-FSH for solid phase ... anti-alpha FSH in the antibody-enzyme ...
Lyophilized, tri-level assayed human serum-based control, Low, intermediate and high levels, Lot-specific target values provided, Suitable for use with RIA, EIA and chemiluminescent,methodo...
... Hormone (FSH) is intimately involved in the ... of the gonadal tissues, which synthesize and ... The levels of circulating FSH is controlled ... feedback relationship. The FSH Quantitative Test ...
Complete product line for typing all classical HLA loci including A, B, C DRA, DRB1, DRB3, DRB4, DRB5, DQA, DQB1, DPA1, and DPB1....
Medicine Products: